An Arizona psychiatrist who was fired last year as an assistant clinical professor at the University of Arizona College of Medicine allegedly because of her desire to conduct research into medical marijuana as a treatment for post-traumatic stress disorder (PTSD) says she will now conduct that research on her own.
Sue Sisley, MD, got some good news recently when a federally regulated Institutional Review Board approved her request for research. But in order to begin, she will need access to the federal government’s supply of marijuana for medical research purposes, which she is waiting for.
“Our goal is to collect the most objective data so that eventually it can be published in peer-reviewed medical journals,” Sisley told Arizona Public Media. She added the work will focus on military veterans.
Last year, Sisley won federal approval to conduct a research project into the therapeutic effect of marijuana on PTSD. Shortly afterwards, the University of Arizona informed her that her appointment there would be terminated, a move that created national headlines.
In December, Sisley and the Multidisciplinary Association for Psychedelic Studies were given a $2 million grant from the Colorado Board of Health to conduct the PTSD study. However, she had been having trouble finding a university to actually house the study. She now says the study will be conducted in the Phoenix area.
A medical marijuana researcher terminated at the University of Arizona last year says she is a step closer to beginning clinical trials in the Phoenix area.
Researcher Sue Sisley said she plans to conduct independent research in the Phoenix area, after she struggled to find support at a state university for a study of marijuana’s effects on people with post-traumatic stress disorder. The private, federally regulated Institutional Review Board approved her research request, she said.
Sisley said the study is now waiting for access to a federal supply of marijuana.
Enjoying our content?
Thanks for visiting Psychiatry Advisor. We hope you’re enjoying the latest clinical news, full-length features, case studies, and more.
You’ve viewed {{metering-count}} of {{metering-total}} articles this month. If you wish to read unlimited content, please log in or register below. Registration is free.
{{login-button}} {{register-button}}
Log in to continue reading this article.
Don’t miss out on today’s top content on Psychiatry Advisor. Register for free and gain unlimited access to:
- Clinical News, with personalized daily picks for you
- Evidence-Based Guidance
- Conference Coverage
- Unique Psychiatry Case Studies
- Full-Length Features
- Drug Monographs
- And More
{{login-button}} {{register-button}}
Want to read more?
Please login or register first to view this content.